Wellington Management Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Buy |
298,688
+54,505
| +22% | +$612K | ﹤0.01% | 1458 |
|
|
2025
Q1 | $1.12M | Sell |
244,183
-117,315
| -32% | -$536K | ﹤0.01% | 1682 |
|
|
2024
Q4 | $2.04M | Buy |
361,498
+14,469
| +4% | +$81.6K | ﹤0.01% | 1550 |
|
|
2024
Q3 | $1.68M | Sell |
347,029
-24,271
| -7% | -$117K | ﹤0.01% | 1576 |
|
|
2024
Q2 | $1.81M | Buy |
371,300
+118,266
| +47% | +$577K | ﹤0.01% | 1538 |
|
|
2024
Q1 | $3.36M | Buy |
253,034
+95,793
| +61% | +$1.27M | ﹤0.01% | 1424 |
|
|
2023
Q4 | $2.19M | Sell |
157,241
-635,285
| -80% | -$8.86M | ﹤0.01% | 1472 |
|
|
2023
Q3 | $10.5M | Sell |
792,526
-183,602
| -19% | -$2.43M | ﹤0.01% | 1096 |
|
|
2023
Q2 | $18.3M | Buy |
976,128
+42,961
| +5% | +$806K | ﹤0.01% | 961 |
|
|
2023
Q1 | $13.5M | Buy |
933,167
+74,065
| +9% | +$1.07M | ﹤0.01% | 1027 |
|
|
2022
Q4 | $16.6M | Sell |
859,102
-151,606
| -15% | -$2.93M | ﹤0.01% | 960 |
|
|
2022
Q3 | $34.7M | Sell |
1,010,708
-252,676
| -20% | -$8.68M | 0.01% | 752 |
|
|
2022
Q2 | $19.3M | Sell |
1,263,384
-1,082,663
| -46% | -$16.5M | ﹤0.01% | 954 |
|
|
2022
Q1 | $53.5M | Sell |
2,346,047
-1,593,461
| -40% | -$36.4M | 0.01% | 734 |
|
|
2021
Q4 | $145M | Sell |
3,939,508
-654,718
| -14% | -$24.1M | 0.02% | 529 |
|
|
2021
Q3 | $214M | Buy |
4,594,226
+628,747
| +16% | +$29.2M | 0.04% | 423 |
|
|
2021
Q2 | $232M | Buy |
+3,965,479
| New | +$232M | 0.04% | 406 |
|